CHADI ABDALLAH to Depression
This is a "connection" page, showing publications CHADI ABDALLAH has written about Depression.
Connection Strength
1.580
-
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation? Pharmacol Ther. 2018 10; 190:148-158.
Score: 0.336
-
Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach. Transl Psychiatry. 2017 02 28; 7(2):e1045.
Score: 0.308
-
Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Ann N Y Acad Sci. 2015 May; 1344:66-77.
Score: 0.268
-
Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT. 2012 Sep; 28(3):157-61.
Score: 0.226
-
mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression. J Affect Disord. 2022 04 15; 303:91-97.
Score: 0.108
-
Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine. Neuropsychopharmacology. 2022 01; 47(1):399-400.
Score: 0.108
-
Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression. Mol Psychiatry. 2018 04; 23(4):824-832.
Score: 0.078
-
Behavioral deficits, abnormal corticosterone, and reduced prefrontal metabolites of adolescent rats subject to early life stress. Neurosci Lett. 2013 Jun 17; 545:132-7.
Score: 0.059
-
Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression. Neuropsychopharmacology. 2024 Nov; 50(1):153-163.
Score: 0.032
-
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. Mol Psychiatry. 2022 12; 27(12):5096-5112.
Score: 0.028
-
Imaging synaptic density in depression. Neuropsychopharmacology. 2023 01; 48(1):186-190.
Score: 0.028